This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
Forget Market Volatility With These 5 Low-Beta Stocks
by Zacks Equity Research
We have figured out a proven strategy that says lucrative returns can also be earned from less-risky stocks if some other parameters are considered.
Acadia Healthcare (ACHC) Beats on Q4 Earnings, Revenues
by Zacks Equity Research
Acadia Healthcare's (ACHC) fourth-quarter 2017 results gained on higher contribution from its facilities in the U.K. and the United States.
Acadia Healthcare (ACHC) Beats on Earnings & Revenues in Q4
by Zacks Equity Research
Acadia Healthcare's (ACHC) fourth-quarter 2017 results gained on higher contribution from its facilities in the U.K. and the United States.
New Strong Buy Stocks for January 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
MEDNAX (MD) in Focus: Stock Moves 13.4% Higher
by Zacks Equity Research
MEDNAX (MD) saw its shares rise over 14% on the day after Elliott Management, a big hedge fund, revealed a 7% stake in the company and said that it seeks to enhance shareholders' value.
Why Mednax (MD) Might Surprise This Earnings Season?
by Zacks Equity Research
Mednax, Inc (MD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP ahead of earnings.
New Strong Sell Stocks for August 4th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
What Makes MEDNAX (MD) a Strong Sell?
by Zacks Equity Research
MEDNAX, Inc. (MD) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
3 Hospital Stocks That Won't Make You Feel Better in Q1
by Zacks Equity Research
The doldrums over the future of Hospital stocks are due to the furor over the final shape of Obamacare or the Affordable Care Act.
Winning Stock Picking Ideas from Last Week's Employment Report
by Kevin Matras
Kevin Matras goes over how to find winning stock-picking ideas in the government's 'boring' economic reports. Highlighted stocks include LIOX, MD and COST.